| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
First Department of Surgery [J. O., Te. Y., Y. K., To. Y., Y. F., T. T.], Department of Surgery, Children's Research Hospital [K. T.], and Department of Biochemistry [H. N., A. I.], Kyoto Prefectural University of Medicine, Kawaramachi-dori, Kamigyo-ku, Kyoto 602, Japan
The induction of ornithine decarboxylase (ODC), a key enzyme of polyamine biosynthesis, is an early and obligatory event in the tumorpromoting step in animal models. The enzyme activity is also elevated in some human premalignant lesions. We determined the ODC activity in human gastric cancer tissue and in the mucosa of cancer-bearing stomach. We concluded that gastric cancer tissue had significantly elevated ODC levels over those of mucosa (157.8 versus 45.7, respectively; P < 0.05). Among mucosa of the stomach, that of the pyloric gland had higher ODC activity than that of the fundic gland (42.8 versus 21.6, respectively; P < 0.05). Moreover, mucosa from the cancer-bearing stomach had high ODC activity compared with gastric mucosa without cancer. ODC activity in cancer tissue and mucosa from cancer-bearing stomach was activated by GTP. In rat experiments, the properties of ODC induced by gastric carcinogen were analyzed. Transiently induced ODC by a single gastric intubation of N-methyl-N'-nitro-N-nitrosoguanidine was not activated by GTP whereas constitutively expressed ODC of N-methyl-N'-nitro-N-nitrosoguanidine-induced cancer-bearing stomach was activated by GTP. These results suggest that some tumor-promoting stimuli may be concerned in human gastric carcinogenesis and that mucosal ODC activity may be a useful marker for assessing the risk of gastric malignancy.
1 To whom requests for reprints should be addressed, at First Department of Surgery, Kyoto Prefectural University of Medicine, Kawaramachi-dori, Kamigyo-ku, Kyoto 602, Japan.
Received 5/25/90. Accepted 12/13/90.
This article has been cited by other articles:
![]() |
L. R. Saunders and E. Verdin Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors. Mol. Cancer Ther., November 1, 2006; 5(11): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Mafune, Y. Tanaka, K. Mimori, M. Mori, K. Takubo, and M. Makuuchi Increased Expression of Ornithine Decarboxylase Messenger RNA in Human Esophageal Carcinoma Clin. Cancer Res., December 1, 1999; 5(12): 4073 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Canizares, J. Salinas, M. d. las Heras, J. Diaz, I. Tovar, P. Martinez, and R. Penafiel Prognostic Value of Ornithine Decarboxylase and Polyamines in Human Breast Cancer: Correlation with Clinicopathologic Parameters Clin. Cancer Res., August 1, 1999; 5(8): 2035 - 2041. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |